{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:05:47Z","timestamp":1780488347305,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.therap.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:28:27Z","timestamp":1735327707000},"page":"438-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lactic acidosis with metformin accumulation in the intensive care units of the Nord Pas de Calais region: A known serious adverse event that can be better prevented"],"prefix":"10.1016","volume":"80","author":[{"given":"Sophie","family":"Gautier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Truong-Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Temime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Granier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hennart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Jaillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2024.12.009_bib0220","series-title":"Le diab\u00e8te en France\u00a0: les chiffres 2020","year":"2021"},{"key":"10.1016\/j.therap.2024.12.009_bib0225","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes care"},{"key":"10.1016\/j.therap.2024.12.009_bib0230","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4239\/wjd.v15.i6.1178","article-title":"Metformin-associated lactic acidosis: a mini review of pathophysiology, diagnosis and management in critically ill patients","volume":"15","author":"See","year":"2024","journal-title":"World J Diabetes"},{"key":"10.1016\/j.therap.2024.12.009_bib0235","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2337\/diacare.21.8.1366","article-title":"Lactic acidosis in metformin therapy. Relationship between plasma metformin concentration and renal function","volume":"21","author":"Lalau","year":"1998","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.therap.2024.12.009_bib0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1179\/acb.2010.104","article-title":"Analysis of 30 case reports of acute poisoning with metformin during long-term therapy","volume":"65","author":"Garat","year":"2010","journal-title":"Clin Belg"},{"key":"10.1016\/j.therap.2024.12.009_bib0245","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40264-013-0038-6","article-title":"The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis","volume":"36","author":"Duong","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.therap.2024.12.009_bib0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.therap.2024.12.009_bib0255","doi-asserted-by":"crossref","first-page":"e29918","DOI":"10.1097\/MD.0000000000029918","article-title":"Clinical presentations and prognosis of metformin-associated lactic acidosis patients in the intensive care unit: a 20-year survey","volume":"101","author":"Yang","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.therap.2024.12.009_bib0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2017.07.039","article-title":"Hyperlactatemia in ICU patients: Incidence, causes and associated mortality","volume":"42","author":"Ferreruela","year":"2017","journal-title":"J Crit Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000528252","article-title":"Metformin's role in hyperlactatemia and lactic acidosis in ICU patients: a systematic review","volume":"108","author":"Mueller","year":"2023","journal-title":"Pharmacology"},{"key":"10.1016\/j.therap.2024.12.009_bib0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2024.12.009_bib0275","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-200932050-00006","article-title":"Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre","volume":"32","author":"Jonville-B\u00e9ra","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.therap.2024.12.009_bib0280","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2710.2010.01192.x","article-title":"Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements","volume":"36","author":"van Berlo-van de Laar","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.therap.2024.12.009_bib0285","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40620-020-00941-8","article-title":"Metformin, chronic nephropathy and lactic acidosis: a multi-faceted issue for the nephrologist","volume":"34","author":"Mariano","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.therap.2024.12.009_bib0290","doi-asserted-by":"crossref","first-page":"R226","DOI":"10.1186\/cc9376","article-title":"Outcome of severe lactic acidosis associated with metformin accumulation","volume":"14","author":"Friesecke","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0295","doi-asserted-by":"crossref","first-page":"3545914","DOI":"10.1155\/2016\/3545914","article-title":"Lactic acidosis in diabetic population: is metformin implicated? Results of a matched case-control study performed on the type 2 diabetes population of Grenoble Hospital University","volume":"2016","author":"Lepelley","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.therap.2024.12.009_bib0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/dc19-0923","article-title":"Reports of lactic acidosis attributed to metformin, 2015-2018","volume":"43","author":"Flory","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0305","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s40264-019-00854-x","article-title":"The association between metformin therapy and lactic acidosis","volume":"42","author":"Kuan","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.therap.2024.12.009_bib0310","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm","volume":"19","author":"Lalau","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.therap.2024.12.009_bib0315","first-page":"45","article-title":"Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review","volume":"17","author":"Renda","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.therap.2024.12.009_bib0320","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s13300-021-01029-7","article-title":"A claims database analysis of dose-dependency of metformin and incidence of lactic acidosis in Japanese patients with type 2 diabetes","volume":"12","author":"Nagai","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.therap.2024.12.009_bib0325","series-title":"Dossier th\u00e9matique. Votre traitement en cas de fortes chaleurs. Point d\u2019information","year":"2024"},{"key":"10.1016\/j.therap.2024.12.009_bib0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4","volume":"41","author":"Lalau","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0335","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s13181-019-00755-6","article-title":"Do patients die with or from metformin-associated lactic acidosis (MALA)? Systematic review and meta-analysis of pH and lactate as predictors of mortality in MALA","volume":"16","author":"Blumenberg","year":"2020","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.therap.2024.12.009_bib0340","doi-asserted-by":"crossref","first-page":"e1194","DOI":"10.1097\/CCM.0000000000004589","article-title":"A study of associations between plasma metformin concentration, lactic acidosis, and mortality in an emergency hospitalization context","volume":"48","author":"Bennis","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.therap.2024.12.009_bib0345","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc7137","article-title":"Metformin-associated lactic acidosis in an intensive care unit","volume":"12","author":"Peters","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0350","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dme.13098","article-title":"Lactic acidosis: relationship between metformin levels, lactate concentration and mortality","volume":"33","author":"Boucaud-Maitre","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.therap.2024.12.009_bib0355","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/15563650.2022.2127363","article-title":"Continuous extracorporeal clearance in metformin-associated lactic acidosis and metformin-induced lactic acidosis: a systematic review","volume":"60","author":"Correia","year":"2022","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.therap.2024.12.009_bib0360","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40620-016-0267-8","article-title":"Metformin associated lactic acidosis (MALA): clinical profiling and management","volume":"29","author":"Moioli","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.therap.2024.12.009_bib0365","doi-asserted-by":"crossref","first-page":"e0273678","DOI":"10.1371\/journal.pone.0273678","article-title":"Metformin-associated lactic acidosis and factors associated with 30-day mortality","volume":"17","author":"Thammavaranucupt","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2024.12.009_bib0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.therap.2024.12.009_bib0375","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/dom.14440","article-title":"Safety and effectiveness of metformin in patients with reduced renal function: a systematic review","volume":"23","author":"Orloff","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.therap.2024.12.009_bib0380","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diacare.18.6.779","article-title":"Role of metformin accumulation in metformin-associated lactic acidosis","volume":"18","author":"Lalau","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2024.12.009_bib0385","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15563650.2019.1648816","article-title":"Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study","volume":"58","author":"Corchia","year":"2020","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.therap.2024.12.009_bib0390","doi-asserted-by":"crossref","first-page":"e00170","DOI":"10.1002\/edm2.170","article-title":"Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: a retrospective nested case-control study","volume":"4","author":"Alvarez","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.therap.2024.12.009_bib0395","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5414\/CNP66380","article-title":"Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?","volume":"66","author":"Gudmundsdottir","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.therap.2024.12.009_bib0400","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-5491.1999.00115.x","article-title":"Contra-indications to metformin therapy are largely disregarded","volume":"16","author":"Holstein","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.therap.2024.12.009_bib0405","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.amjms.2022.01.026","article-title":"Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: the REMIND-TMU study","volume":"364","author":"Chen","year":"2022","journal-title":"Am J Med Sci"},{"issue":"Suppl. 3","key":"10.1016\/j.therap.2024.12.009_bib0410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dom.15749","article-title":"Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes","volume":"26","author":"Silverii","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.therap.2024.12.009_bib0415","series-title":"Acidose lactique li\u00e9e \u00e0 la metformine\u00a0: connaissances des facteurs de risque et pr\u00e9vention par les m\u00e9decins g\u00e9n\u00e9ralistes du Nord et du Pas-de-Calais","author":"Allouchery","year":"2020"},{"key":"10.1016\/j.therap.2024.12.009_bib0420","series-title":"Actualit\u00e9. Acidose lactique et metformine: un risque \u00e9vitable","year":"2023"},{"key":"10.1016\/j.therap.2024.12.009_bib0425","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.3390\/ijms23158320","article-title":"Metformin: when should we fear lactic acidosis?","volume":"23","author":"Di Mauro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.therap.2024.12.009_bib0430","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.therap.2016.05.006","article-title":"Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?","volume":"71","author":"S\u00e9mely","year":"2016","journal-title":"Therapie"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572400218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572400218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:47:30Z","timestamp":1762220850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059572400218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S004059572400218X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.12.009","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactic acidosis with metformin accumulation in the intensive care units of the Nord Pas de Calais region: A known serious adverse event that can be better prevented","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}